2.Cefepime-Induced Nonconvulsive Status Epileticus Presenting as Coma in a Patient with ESRD on Hemodialysis.
Cho I LEE ; Mi Jin HONG ; Sung Chul HONG ; Jung Hee PARK ; Eugene PARK ; Jang Soo HAN ; Young Jin KIM ; Jong Ho LEE ; Jung Hwan PARK ; Jong Oh SONG ; Young Il JO
Korean Journal of Nephrology 2011;30(5):537-541
Cefepime-induced nonconvulsive status epilepticus (NCSE) in end-stage renal disease (ESRD) patients receiving hemodialysis has only rarely been reported. Here we report a case of cefepime-induced NCSE presenting as coma in a patient with ESRD on hemodialysis. A 73-year-old man, who had been receiving maintenance hemodialysis, developed aphasia and coma during cefepime therapy for epidural abscess. Emergent eletroencephalography (EEG) revealed evidence of NCSE. The abnormal EEG findings were resolved and comatose mentality was completely recovered after cessation of cefepime and administration of anticonvulsive drugs. Cefepime-induced NCSE should be considered if neurological symptoms including comatose mentality develops during cefepime therapy in a patient with renal failure.
Aged
;
Anticonvulsants
;
Aphasia
;
Cephalosporins
;
Coma
;
Electroencephalography
;
Epidural Abscess
;
Humans
;
Kidney Failure, Chronic
;
Renal Dialysis
;
Renal Insufficiency
;
Status Epilepticus
3.Association of acute tubular necrosis with gross hematuria in cirrhosis-related immunoglobulin A nephropathy.
Jang Soo HAN ; So Dug LIM ; Won Hyeok CHOI ; Sung Chul HONG ; Jung Hee PARK ; Eugene PARK ; Mi Jin HONG ; Cho I LEE ; Jung Hwan PARK ; Jong Ho LEE ; Jong Oh SONG ; Young Il JO
Kidney Research and Clinical Practice 2013;32(1):43-46
Immunoglobulin A (IgA) nephropathy associated with cirrhosis is the most common form of secondary IgA nephropathy (IgAN). Cirrhosis-related IgAN is usually clinically silent with a rare occurrence of gross hematuria, unlike in cases of idiopathic IgAN. Especially, acute tubular necrosis (ATN) associated with gross hematuria is very rare in cirrhosis-related IgAN, although acute renal failure is a frequently reported complication in advanced cirrhosis. Herein, we report an unusual case of ATN requiring renal replacement therapy, associated with gross hematuria in a patient with nonalcoholic, hepatitis B virus-associated cirrhosis. Results of a histopathological analysis revealed obstruction of the lumen of renal tubules by red blood cell casts, a marked tubular necrosis, and IgA deposition in the mesangium. The patient's renal function and gross hematuria were clearly improved after lamivudine treatment.
Acute Kidney Injury
;
Erythrocytes
;
Fibrosis
;
Glomerulonephritis, IGA
;
Hematuria
;
Hepatitis B
;
Humans
;
Immunoglobulin A
;
Immunoglobulins
;
Lamivudine
;
Necrosis
;
Renal Insufficiency
;
Renal Replacement Therapy
4.Association of acute tubular necrosis with gross hematuria in cirrhosis-related immunoglobulin A nephropathy.
Jang Soo HAN ; So Dug LIM ; Won Hyeok CHOI ; Sung Chul HONG ; Jung Hee PARK ; Eugene PARK ; Mi Jin HONG ; Cho I LEE ; Jung Hwan PARK ; Jong Ho LEE ; Jong Oh SONG ; Young Il JO
Kidney Research and Clinical Practice 2013;32(1):43-46
Immunoglobulin A (IgA) nephropathy associated with cirrhosis is the most common form of secondary IgA nephropathy (IgAN). Cirrhosis-related IgAN is usually clinically silent with a rare occurrence of gross hematuria, unlike in cases of idiopathic IgAN. Especially, acute tubular necrosis (ATN) associated with gross hematuria is very rare in cirrhosis-related IgAN, although acute renal failure is a frequently reported complication in advanced cirrhosis. Herein, we report an unusual case of ATN requiring renal replacement therapy, associated with gross hematuria in a patient with nonalcoholic, hepatitis B virus-associated cirrhosis. Results of a histopathological analysis revealed obstruction of the lumen of renal tubules by red blood cell casts, a marked tubular necrosis, and IgA deposition in the mesangium. The patient's renal function and gross hematuria were clearly improved after lamivudine treatment.
Acute Kidney Injury
;
Erythrocytes
;
Fibrosis
;
Glomerulonephritis, IGA
;
Hematuria
;
Hepatitis B
;
Humans
;
Immunoglobulin A
;
Immunoglobulins
;
Lamivudine
;
Necrosis
;
Renal Insufficiency
;
Renal Replacement Therapy
5.A Case of Scleredema Associated with Dermatomyositis.
Jung Hee PARK ; Sang Heon LEE ; Jung Hwa LEE ; Sung Chul HONG ; Mi Jin HONG ; Eugene PARK ; Jang Soo HAN ; Cho I LEE ; So Mi KIM ; Hae Rim KIM
Journal of Rheumatic Diseases 2011;18(4):324-326
Dermatomyositis (DM) is rare systemic inflammatory disease with typical skin manifestations and muscular involvement. Various skin lesions can accompany this disease, such as Gottron's sign, Heliotrope rash, mechanic's hands, V sign and shawl sign. Scleredema is a very rare skin manifestation in DM. We report a case of DM in a 63-year-old woman, who had scleredema on her thighs. A diagnosis of DM was established by clinical manifestation, elevated muscle enzyme levels, electromyogram measures, and muscle biopsy findings. She was successfully treated with the immunosuppressants methotrexate, cyclosporine, and steroids (low dose).
Biopsy
;
Cyclosporine
;
Dermatomyositis
;
Exanthema
;
Female
;
Hand
;
Humans
;
Immunosuppressive Agents
;
Methotrexate
;
Middle Aged
;
Muscles
;
Scleredema Adultorum
;
Skin
;
Skin Manifestations
;
Steroids
;
Thigh
6.The Clinical Characteristics and Outcomes of Patients with Moderate-to-Severe Coronavirus Disease 2019 Infection and Diabetes in Daegu, South Korea
Mi Kyung KIM ; Jae-Han JEON ; Sung-Woo KIM ; Jun Sung MOON ; Nan Hee CHO ; Eugene HAN ; Ji Hong YOU ; Ji Yeon LEE ; Miri HYUN ; Jae Seok PARK ; Yong Shik KWON ; Yeon-Kyung CHOI ; Ki Tae KWON ; Shin Yup LEE ; Eon Ju JEON ; Jin-Woo KIM ; Hyo-Lim HONG ; Hyun Hee KWON ; Chi Young JUNG ; Yin Young LEE ; Eunyeoung HA ; Seung Min CHUNG ; Jian HUR ; June Hong AHN ; Na-young KIM ; Shin-Woo KIM ; Hyun Ha CHANG ; Yong Hoon LEE ; Jaehee LEE ; Keun-Gyu PARK ; Hyun Ah KIM ; Ji-Hyun LEE
Diabetes & Metabolism Journal 2020;44(4):602-613
Coronavirus disease 2019 (COVID-19) is a global pandemic that had affected more than eight million people worldwide by June 2020. Given the importance of the presence of diabetes mellitus (DM) for host immunity, we retrospectively evaluated the clinical characteristics and outcomes of moderate-to-severe COVID-19 in patients with diabetes. We conducted a multi-center observational study of 1,082 adult inpatients (aged ≥18 years) who were admitted to one of five university hospitals in Daegu because of the severity of their COVID-19-related disease. The demographic, laboratory, and radiologic findings, and the mortality, prevalence of severe disease, and duration of quarantine were compared between patients with and without DM. In addition, 1:1 propensity score (PS)-matching was conducted with the DM group. Compared with the non-DM group ( DM is a significant risk factor for COVID-19 severity and mortality. Our findings imply that COVID-19 patients with DM, especially if elderly, require special attention and prompt intensive care.